Curtiss Dentistry of Maryville Introduces Cutting-Edge iTero Digital Scanning Technology
MARYVILLE, TN / ACCESSWIRE / November 7, 2024 / Curtiss Dentistry a dental practice in Maryville TN is excited to...
News
REMORY: A Sea Squirt-Derived Plasmalogen Supplement Expands in the U.S. Market
REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and...
Paradigm Treatment to Open New Residential Mental Health Facility in Coeur d’Alene, Idaho
The new facility will feature beds for both teen and adult patients, ensuring greater access to mental health care for...
Pasadena Villa Outpatient Expands Mental Health Treatment Services Into Pennsylvania With New Pittsburgh Clinic
BRENTWOOD, TN / ACCESSWIRE / November 7, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health treatment services,...
Lexaria Updates Fast-Moving GLP-1 ‘Arm’s Race’ Developments
DehydraTECH™ for GLP-1 being optimized for global pharmaceutical use KELOWNA, BC / ACCESSWIRE / November 7, 2024 / Lexaria Bioscience...
Hear at Last Signs a Canada Wide Distribution with Hohm Pods for Portable Home Pods
Toronto, Ontario--(Newsfile Corp. - November 7, 2024) - HearAtLast Holdings, Inc. (OTC Pink: HRAL), is excited to work with Hohm...
Vitaquest Hires David Alcaraz as Senior Vice President, Quality Assurance
Alcaraz brings nearly 20 years of experience in quality management to the roleWest Caldwell, New Jersey--(Newsfile Corp. - November 7,...
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
Common Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November...
NervGen Pharma to Present at the Stifel 2024 Healthcare Conference
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company...
Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update
Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is...
Ludwig Enterprises Begins PCR Validation Test Process
Final step before the full launch of breast cancer screening program, Revealia™SPARKS, NV / ACCESSWIRE / November 7, 2024 /...
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
Revenue increased 31% for the quarter compared to same period prior yearPositive cash flows from operations of $0.35 million for...
Med-X Secures Coveted OMRI Listing for Nature-Cide All-Purpose Commercial Concentrate to Allow for Use in Certified Organic Food Processing Facilities
Leading Organic Trade Organization Lists Nature-Cide All-Purpose Commercial Concentrate as Allowed for the Use in Accordance with the National Organic...
Aptevo Therapeutics Reports 3Q 2024 Financial Results and Provides a Business Update
Company Achieves Milestones in Both Clinical ProgramsInitiates Mipletamig Phase 1b/2 Clinical Trial, "RAINIER," in Frontline Acute Myeloid Leukemia, Informed by...
CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling
The global cannabis market size was valued at USD 43.72 billion in 2022 and is projected to grow from USD...
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
-Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid...
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 7, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
TRNR Announces 1-for-100 Reverse Split
Split Becomes Effective Monday, November 11, 2024Shareholder- and Board-Approved Action Reduces Shares Outstanding to 313,235 from 31 Million, Ensures Continued...
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03Achieves year-to-date product...
Promising cooperation between medac and chiron for the development of organ-on chip technology
WEDEL, Germany, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Testing new substances in animals is a regulatory cornerstone of drug development....